(TheNewswire)
Vancouver, British Columbia – TheNewswire - August 9 th , 2022 –Blackhawk Growth Corp. (the “Company”) (CSE:BLR ) ; (CNSX:BLR.CN);(OTC:BLRZF); ( Frankfurt:0JJ) is pleased to announce that the Board ofDirectors have set a date for the Company’s Annual General Meeting(“AGM”). The AGM will be held September 30th, 2022. Furtherinformation regarding the matters to be considered at the AGM will beincluded in a management information circular being prepared by theCompany and which will be distributed to shareholders prior to theAGM.
Operations Update
MindBio Therapeutics
MindBio is making progress with unblinding andcollation of data from Phase 1 Microdosing Clinical Trials that werecompleted in April 2022. A formal presentation of Phase 1 clinicaltrial results is planned for November in the US via a press conferencethen a keynote presentation at a major industry event.
The data analysis is extensive and includes a machinelearning process to identify trends and connections across thousandsof psychometric and biological data sets. A speech recognitionalgorithm is also being used to analyse the qualitative data from 2hour post treatment interviews in both the treatment and placebogroups. The information gained from these analytical processes formsthe foundation for MindBio’s microdosing predictive treatment modeland intellectual property development for the purposes ofcommercializing a medical treatment using proprietary technology andpsychedelic microdosing.
Preparations for Phase 2 clinical trials areprogressing well and management is encouraged by the early data seenfrom phase 1 results that is informative and positive news forcontinuation trials. A new digital app has been created for use byparticipants in Phase 2 clinical trials. The digital app is animportant part of the treatment protocol and has a user friendlyinterface to monitor mood, adherence, safety measures and to collectpsychometric data and record the experience of patients. Clinicaltrial participants will also use wearables to collect biometric dataduring their treatment cycle. The digital app is currently beingenhanced with capability to deliver a clinically proven psychologicaltreatment intervention to be used in conjunction with medicinalmicrodosing. The digital app will feed psychometric and biometricdata back to clinicians in real time in future clinical trials.
Management is committed to moving forward with theproposed spin out of MindBio with preparations for the spin outcontinuing.
Terp Wholesale
Terp continues to show growth. The Company hasactivated its delivery and is developing new and exciting productsthat are driving sales. Blackhawk’s management team is currentlyreviewing and confirming their 2021 revenue numbers and will publishthem once the review is complete.
Sac Pharma Partners Inc.
Sac Pharma continues to grow top quality dried flowercannabis for the California market. Sac Pharma’s genetic library isalso growing. It is currently operating at capacity and expansionplans are in development. Management will provide revenue figureswhen they become available.
Noble Hemp
Blackhawk has suspended operations for this initiative.Profitability as well as lack of staff are the main drivers for thisdecision. The Company will maintain the intellectual property andbranding with the potential to explore relaunch at some point in thefuture.
Leictmind/Trip Pharma
Dr. Krista Leict has resigned from her position citingpersonal and professional changes. Management of Blackhawk hassuspended all operations of this initiative.
Stable Foods
Stable Foods continues to prepare its products forlarge scale commercial sales. Formulation, equipment changes andcalibration have been in progress to ensure the highest qualityproduct will be manufactured and sold by Stable Foods. In addition, toaccommodate the expected demand. Stable foods is currently moving intoa new state of the art 32,000 square foot food-grade facility. It willcontinue to share the space with Specialty D Baking and will utilizeits own as well as Specialty D’s distribution channels to getproducts to market.
Spaced Food
Tru Extracts Calgary is in the final stages inpreparation for retail sales of Spaced Food. They have redeveloped theproduct, added sku’s and are now preparing the retail displays,media and merchandising. News updates will come in tandem from theCompany and Tru Extracts parent company Gaia Grow Corp. (CSE:GAIA).
About Blackhawk Growth
Blackhawk is an investment holding company looking tocreate substantial value for its shareholders through the acquisitionand development of high growth companies. It has focused itsinvestments in the health, cannabis and cannabidiol industries in bothCanada and the United States. Its portfolio of companies includes TERPWholesale, Sac Pharma, LeichtMind Clinics, Noble Hemp, Spaced Food,NuWave Foods, MindBio Therapeutics, Digital Mind Technology as well asan equity position in Gaia Grow Corp. (CSE:GAIA) .
The Company diligently posts updates through videosfrom the official company YouTube channel https://www.youtube.com/channel/UCs4f2tt3yAvOGhNLjgNOy-A
Please join the conversation on our Blackhawk groupsupporter’s telegram group at https://t.me/Blackhawkgrowthcorp and visit us online at https://www.blackhawkgrowth.com .
For further information please contact:
Frederick Pels, Chief ExecutiveOfficer
(403)-991-7737
fred@ blackhawkgrowth.com
Cautionary NoteRegarding Forward-Looking Statement
All statements in this pressrelease, other than statements of historical fact, are “forward-looking information”with respect to the Corporation within the meaning of applicablesecurities laws. The Corporation provides forward-looking statementsfor the purpose of conveying information about current expectationsand plans relating to the future and readers are cautioned that suchstatements may not be appropriate for other purposes. By its nature,this information is subject to inherent risks and uncertainties thatmay be general or specific and which give rise to the possibility thatexpectations, forecasts, predictions, projections or conclusions willnot prove to be accurate, that assumptions may not be correct and thatobjectives, strategic goals and priorities will not be achieved. Theserisks and uncertainties include but are not limited those identifiedand reported in the Corporation ’s public filings under theCorporation’s SEDAR profile at www.sedar.com. Although theCorporation has attempted to identify important factors that couldcause actual actions, events or results to differ materially fromthose described in forward-looking information, there may be otherfactors that cause actions, events or results not to be asanticipated, estimated or intended. There can be no assurance thatsuch information will prove to be accurate as actual results andfuture events could differ materially from those anticipated in suchstatements. The Corporation disclaims any intention or obligation toupdate or revise any forward-looking information, whether as a resultof new information, future events or otherwise unless required bylaw.
Copyright (c) 2022 TheNewswire - All rights reserved.